67-5

75/110

) Yao T, Wada R: Pathology of gastric cancer. In: Shiotani A. ed. Gastric cancer. With special focus on studies from Japan. Singapore: T, Takamochi K, Oh S, Suzuki K: Distinct clinicopathological characteristics and prog-nosis based on the presence of ground glass opacity component in clinical-stage IA lung adenocarcinoma. J Thorac Oncol. 2019 Feb; 14: 265-275. 13) Nakanuma Y, Kakuda Y, Fukumura Y, Sugino T, Uesaka K, Serizawa M, Terada T, Ohnishi Y: The pathologic and genetic characteristics of the intestinal subtype of intraductal papil-lary neoplasms of the bile duct. Am J Surg Pathol. 2019; 43: 1212-1220. 14) Matsuda Y, Masuda Y, Shimoji K, Matsu-kawa M, Kinowaki Y, Fukumura Y, Kikuyama M, Arai T: Severe acute pancreatitis in autop-sies associated with surgeries and severe inflammatory diseases. Pancreas 2019; 48: 1321-1328. 15) Sugimoto K, Ito T, Hulbert A, Chen C, Orita H, Maeda M, Moro H, Fukagawa T, Ushijima T, Katai H, Wada R, Sato K, Sakamoto K, Yu W, Considine M, Cope L, Brock MV: DNA methylation genome-wide analysis in remnant and primary gastric cancers. Gastric Cancer. 2019; 22: 1109-20. 16) Shimizu Y, Wakabayashi K, Hayashi Y, Hara K, Aoyama R, Niimi T, Tomino Y, Wada R, Hata M, Suzuki Y: MPGN Type 3 Associated with Pemphigus Herpetiformis Mimicking PGNMID and Dermatitis Herpetiformis. Case Rep Nephrol Dial. 21; 2019; 9: 15-24. 17) Ito T, Matoba R, Maekawa H, Sakurada M, Kushida T, Orita H, Wada R, Sato K: Detec-tion of gene mutations in gastric cancer tissues using a commercial sequencing panel. Molec-ular and Clinical Oncology. 2019; 11: 455-460. 18) Asahina M, Saito T, Hayashi T, Fukumura Y, Mitani K, Yao T: Clinicopathological effect of PLAG1 fusion genes in pleomorphic adenoma and carcinoma ex pleomorphic adenoma with special emphasis on histological features. Histopathology. 2019; 74: 514-525. doi: 10.1111/his.13759. 19) Akazawa Y, Hayashi T, Saito T, Niwa K, Kamiyama H, Sasahara N, Sakamoto K, Naga-hara A, Yao T: Histological characteristics of eosinophilic myenteric ganglionitis, an under- recognised cause of chronic intestinal pseu-do-obstruction. Virchows Arch. 2019 Jan 4. doi: 10.1007/s00428-018-02513-5. 20) Yatagai N, Saito T, Akazawa Y, Hayashi T, Yanai Y, Tsuyama S, Ueyama H, Murakami T, Watanabe S, Nagahara A, Yao T: Frequent loss of heterozygosity of SMAD4 locus and prognostic impacts of SMAD4 immunohisto-chemistry in gastric adenocarcinoma with enteroblastic differentiation. Human Pathol. 2019 Jun; 88: 18-26. doi: 10.1016/j.humpath. 2019.03.005. Epub 2019 Apr 1. 21) Yatagai N, Saito T, Akazawa Y, Hayashi T, Yanai Y, Tsuyama S, Ueyama H, Murakami T, Watanabe S, Nagahara A, Yao T: TP53 inactivation and expression of methylation- associated proteins in gastric adenocarcinoma with enteroblastic differentiation. Virchows Archiv. 2019 Mar; 474: 315-324. doi: 10.1007/s00428-018-2508-9. Epub 2018 Dec 15. 22) Suehara Y, Mukaihara K, Okubo T, Kurihara T, Hayashi T, Kohsaka S, Kazuno S, Keisuke Akaike K, Kim Y, Kaneko K, Saito T: Protein Expression Profiles Corresponding to Histo-logical Changes with Denosumab Treatment in Giant Cell Tumors of Bone. PROTEOMICS - Clinical Applications. 2019 Jul 9: e1800147. doi: 10.1002/prca.201800147. 23) Tsuyama S, Saito T, Akazawa Y, Yanai Y, Akaike K, Hayashi T, Suehara Y, Takahashi F, Takamochi K, Hashimoto T, Kajiyama Y, Tsurumaru M, Fukunaga T, Takashi Yao T: Molecular and clinicopathological analyses in esophageal carcinosarcoma with special refer-ence on the differentiation mechanism. Virchows Archiv. 2019 Oct; 475: 415-424. doi: 10.1007/s00428-019-02643-4. Epub 2019 Aug 23. 24) Inoue S, Hirota Y, Ueno T, Fukui Y, Yoshida E, Hayashi T, Kojima S, Takeyama R, Hashimoto T, Kiyono T, Taguchi A, Tanaka T, Tanaka Y, Ikemura M, Sakata S, Takeuchi K, Muraoka A, Osuka S, Saito T, Oda K, Osuga Y, Terao Y, Kawazu M, Mano H: Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations. Nat Comm. 2019 Dec 19; 10: 5785. doi: 10.1038/s41467-019-13708-y.〈Books〉 1479